Use the pullback to buy pullback in this MedTech stock: JPMorgan
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
This MedTech stock surge could surge after earnings says TD CowenThis MedTech stock surge could surge after earnings says TD Cowen
Read more »
MedTech stocks: Q2 earnings season previewMedTech stocks: Q2 earnings season preview
Read more »
This San Diego medtech company is cutting 117 jobsLocal subsidiary of medtech giant Becton Dickinson & Co. is cutting jobs at two San Diego sites.
Read more »
Here are JPMorgan's top stock picks for AugustJPMorgan updated its Analyst Focus List for August, including one addition and two removals from July.
Read more »
JPMorgan sees near 20% upside left in Apple stock, adds it to focus listJPMorgan sees near 20% upside left in Apple stock, adds it to focus list
Read more »
Here are JPMorgan's top drug stock picks into earningsThese are JPMorgan's top drug picks heading into earnings.
Read more »